{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:30:37Z","timestamp":1792510237923,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:00:00Z","timestamp":1612656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:00:00Z","timestamp":1612656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS065736"],"award-info":[{"award-number":["U54NS065736"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS107596"],"award-info":[{"award-number":["R01NS107596"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018889","name":"Multiple System Atrophy Coalition","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018889","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10286-021-00782-w","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T04:35:30Z","timestamp":1612845330000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1345-6774","authenticated-orcid":false,"given":"Jose-Alberto","family":"Palma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio Millar","family":"Vernetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Seppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fanciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Norcliffe-Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Pellecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Merello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Betensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Wenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,7]]},"reference":[{"key":"782_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1212\/WNL.0000000000008208","volume":"93","author":"P Cortelli","year":"2019","unstructured":"Cortelli P, Calandra-Buonaura G, Benarroch EE, Giannini G, Iranzo A, Low PA, Martinelli P, Provini F, Quinn N, Tolosa E, Wenning GK, Abbruzzese G, Bower P, Alfonsi E, Ghorayeb I, Ozawa T, Pacchetti C, Pozzi NG, Vicini C, Antonini A, Bhatia KP, Bonavita J, Kaufmann H, Pellecchia MT, Pizzorni N, Schindler A, Tison F, Vignatelli L, Meissner WG (2019) Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment. Neurology 93:630\u2013639","journal-title":"Neurology"},{"key":"782_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69\u201372","journal-title":"Clin Auton Res"},{"key":"782_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/mds.20678","volume":"21","author":"F Geser","year":"2006","unstructured":"Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba JP, Ulmer H, Pellecchia MT, Barone P, Kim HT, Hooker J, Quinn NP, Cardozo A, Tolosa E, Abele M, Klockgether T, Ostergaard K, Dupont E, Schimke N, Eggert KM, Oertel W, Djaldetti R, Poewe W, European MSASG (2006) Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 21:179\u2013186","journal-title":"Mov Disord"},{"key":"782_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/mds.25181","volume":"27","author":"F Krismer","year":"2012","unstructured":"Krismer F, Seppi K, Tison F, Sampaio C, Zangerl A, Peralta C, Yekhlef F, Ghorayeb I, Ory-Magne F, Galitzky M, Bozi M, Scaravilli T, Colosimo C, Geser F, Rascol O, Poewe W, Quinn NP, Wenning GK, European Multiple System Atrophy Study G (2012) The unified multiple system atrophy rating scale: intrarater reliability. Mov Disord 27:1683\u20131685","journal-title":"Mov Disord"},{"key":"782_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S1474-4422(19)30141-3","volume":"18","author":"J Levin","year":"2019","unstructured":"Levin J, Maass S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Sudmeyer M, Eggert K, Mollenhauer B, Lipp A, Lohle M, Classen J, Munchau A, Kassubek J, Gandor F, Berg D, Egert-Schwender S, Eberhardt C, Paul F, Botzel K, Ertl-Wagner B, Huppertz HJ, Ricard I, Hoglinger GU, Group PS (2019) Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 18:724\u2013735","journal-title":"Lancet Neurol"},{"key":"782_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","volume":"14","author":"PA Low","year":"2015","unstructured":"Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J (2015) Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 14:710\u2013719","journal-title":"Lancet Neurol"},{"key":"782_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(13)70301-6","volume":"13","author":"PA Low","year":"2014","unstructured":"Low PA, Robertson D, Gilman S, Kaufmann H, Singer W, Biaggioni I, Freeman R, Perlman S, Hauser RA, Cheshire W, Lessig S, Vernino S, Mandrekar J, Dupont WD, Chelimsky T, Galpern WR (2014) Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 13:268\u2013275","journal-title":"Lancet Neurol"},{"key":"782_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10286-020-00681-6","volume":"30","author":"J Martinez","year":"2020","unstructured":"Martinez J, Palma JA, Norcliffe-Kaufmann L, Garakani A, Kaufmann H (2020) Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials. Clin Auton Res 30:215\u2013221","journal-title":"Clin Auton Res"},{"key":"782_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2017.12.001","volume":"48","author":"F Ory-Magne","year":"2018","unstructured":"Ory-Magne F, Pellaprat J, Harroch E, Galitzsky M, Rousseau V, Pavy-Le Traon A, Rascol O, Gerdelat A, Brefel-Courbon C (2018) Abnormal pain perception in patients with Multiple System Atrophy. Parkinsonism Relat Disord 48:28\u201333","journal-title":"Parkinsonism Relat Disord"},{"key":"782_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mds.27344","volume":"33","author":"JA Palma","year":"2018","unstructured":"Palma JA, Kaufmann H (2018) Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 33:372\u2013390","journal-title":"Mov Disord"},{"key":"782_CR11","doi-asserted-by":"crossref","unstructured":"Palma JA, Martinez J, Barnes E, Simon S, Norcliffe-Kaufmann L, Kaufmann H (2019) A futility trial of Sirolimus in multiple system atrophy: protocol, recruitment and preliminary adverse event profile (P3.8-019). Neurology 92:P3.8-019","DOI":"10.1212\/WNL.92.15_supplement.P3.8-019"},{"key":"782_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.autneu.2017.10.007","volume":"211","author":"JA Palma","year":"2018","unstructured":"Palma JA, Norcliffe-Kaufmann L, Kaufmann H (2018) Diagnosis of multiple system atrophy. Autonomic Neurosci: Basic Clin 211:15\u201325","journal-title":"Autonomic Neurosci: Basic Clin"},{"key":"782_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(14)70288-1","volume":"14","author":"W Poewe","year":"2015","unstructured":"Poewe W, Seppi K, Fitzer-Attas CJ, Wenning GK, Gilman S, Low PA, Giladi N, Barone P, Sampaio C, Eyal E, Rascol O, Rasagiline-for MSAi (2015) Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial. Lancet Neurol 14:145\u2013152","journal-title":"Lancet Neurol"},{"key":"782_CR14","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1212\/WNL.0000000000007720","volume":"93","author":"W Singer","year":"2019","unstructured":"Singer W, Dietz AB, Zeller AD, Gehrking TL, Schmelzer JD, Schmeichel AM, Gehrking JA, Suarez MD, Sletten DM, Minota Pacheco KV, Coon EA, Sandroni P, Benarroch EE, Fealey RD, Matsumoto JY, Bower JH, Hassan A, McKeon A, Windebank AJ, Mandrekar JN, Low PA (2019) Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy. Neurology 93:e77\u2013e87","journal-title":"Neurology"},{"key":"782_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10286-015-0281-2","volume":"25","author":"W Singer","year":"2015","unstructured":"Singer W, Low PA (2015) Optimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study. Clin Auton Res 25:47\u201352","journal-title":"Clin Auton Res"},{"key":"782_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","volume":"12","author":"GK Wenning","year":"2013","unstructured":"Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W, European Multiple System Atrophy Study G (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12:264\u2013274","journal-title":"Lancet Neurol"},{"key":"782_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.20255","volume":"19","author":"GK Wenning","year":"2004","unstructured":"Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, Ghorayeb I, Ory F, Galitzky M, Scaravilli T, Bozi M, Colosimo C, Gilman S, Shults CW, Quinn NP, Rascol O, Poewe W, Multiple System Atrophy Study G (2004) Development and validation of the unified multiple system atrophy rating scale (UMSARS). Mov Disord 19:1391\u20131402","journal-title":"Mov Disord"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-021-00782-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-021-00782-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-021-00782-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:33:31Z","timestamp":1744151611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-021-00782-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,7]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s10286-021-00782-w","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,7]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Palma: salary from Novartis Gene Therapies. Research funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, FDA, and Biogen; advisory board member for Lundbeck, Biogen, PTC Therapeutics, Astellas, and Dr. Reddy\u2019s Laboratories; managing editor of Clinical Autonomic Research; principal investigator in MSA studies funded by Biohaven Pharmaceuticals, Theravance Biopharma, and Biogen. Dr. Millar: research funding from the Familial Dysautonomia Foundation and Theravance Biopharma. Mr. Perez: research funding from the Familial Dysautonomia Foundation. Dr. Krismer: funding support from MSA Coalition, non-financial support from International Parkinson\u2019s Disease and Movement Disorders Society, non-financial support from Austrian Parkinson\u2019s Disease Society. Dr. Fanciulli: royalties from Springer Nature Publishing Group, Thieme Verlag and IOS Press, speaker fees and honoraria from the Austrian Parkinson Society, International Parkinson Disease and Movement Disorders Society, French Cardiology Society, Theravance Biopharma and research Grants from the Stichting Parkinson Fond, the \u00d6sterreichischer Austausch Dienst and the MSA Coalition. Dr. Norcliffe-Kaufmann: research funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, FDA; advisory fees from Theravance Biopharma, and PTC Therapeutics. Dr. Kim: research finding from Seoul National University Hospital and C-TRI. Dr. Merello: Editor-in-Chief of Movement Disorders Clinical Practice. Dr. Stankovic: speaker honoraria from International Parkinson Disease and Movement Disorders Society. Dr. Kaufmann: research funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, FDA, and Biogen; is an advisory Board Member for Lundbeck, Biogen, Biohaven, Theravance, PTC Therapeutics, ONO and Lilly; is Editor-in-Chief of Clinical Autonomic Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}